Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A.
Institute for Health and Equity, Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, U.S.A.
Laryngoscope. 2020 Apr;130(4):961-966. doi: 10.1002/lary.28182. Epub 2019 Jul 22.
Laryngopharyngeal reflux (LPR) is a common upper airway disease. Salivary pepsin is a proposed marker for LPR; however, the optimal time for collection of specimens for pepsin detection and pepsin's presence in the oral and nasal secretions relative to concurrent multichannel intraluminal impedance-pH (MII-pH) monitoring are unknown.
Prospective case-control study with an experimental design.
Patients undergoing MII-pH testing for evaluation of LPR and asymptomatic control subjects were selected. Nasal lavage and saliva samples were collected in the clinic prior to MII-pH probe placement. Additional saliva samples were obtained an hour after each meal and upon waking the following morning. Nasal lavage and salivary pepsin were measured by ELISA.
Twenty-six patients undergoing MII-pH testing and 13 reflux-free control patients were enrolled. Salivary pepsin was detected in 11 of 26 patients with suspected LPR and 0 of 13 controls. Pepsin was most frequently detected in the specimen provided upon waking at an average concentration of 186.9 ng/mL. A significant correlation was observed between salivary pepsin in waking samples to MII-pH measurements, including reflux bolus duration, and proximal and distal recumbent reflux episodes (P < 0.05). A significant correlation was also observed between salivary pepsin upon waking or sinus lavage and reflux symptom index (P < 0.05).
Pepsin in salivary and nasal lavage samples demonstrated an association with MII-pH-documented LPR. Pepsin detection was most frequent in morning samples, supporting use of morning salivary pepsin levels as a potential noninvasive technique for LPR diagnosis.
2 Laryngoscope, 130:961-966, 2020.
喉咽反流(LPR)是一种常见的上呼吸道疾病。唾液胃蛋白酶是 LPR 的一个拟议标志物;然而,收集胃蛋白酶标本以进行检测的最佳时间,以及胃蛋白酶在口腔和鼻腔分泌物中的存在与同时进行的多通道腔内阻抗-pH(MII-pH)监测之间的关系尚不清楚。
前瞻性病例对照研究,采用实验设计。
选择接受 MII-pH 测试以评估 LPR 的患者和无症状对照者。在 MII-pH 探头放置前,在诊所采集鼻冲洗液和唾液样本。在每餐和次日清晨醒来后,额外采集唾液样本。通过 ELISA 测量鼻冲洗液和唾液胃蛋白酶。
共纳入 26 例接受 MII-pH 测试的患者和 13 例无反流对照者。在 26 例疑似 LPR 患者中,有 11 例检测到唾液胃蛋白酶,而在 13 例对照者中则未检测到。胃蛋白酶最常于清晨醒来时提供的样本中检测到,平均浓度为 186.9ng/ml。在清晨样本中,胃蛋白酶与 MII-pH 测量值之间,包括反流物持续时间、近端和远端卧位反流事件,观察到显著相关性(P<0.05)。在清晨或鼻窦冲洗液中的唾液胃蛋白酶与反流症状指数之间,也观察到显著相关性(P<0.05)。
唾液和鼻冲洗液样本中的胃蛋白酶与 MII-pH 记录的 LPR 之间存在关联。清晨样本中胃蛋白酶检测最常见,支持使用清晨唾液胃蛋白酶水平作为 LPR 诊断的潜在非侵入性技术。
2 级喉镜检查,130:961-966,2020 年。